ACADIA PHARMACEUTICALS INC.: accounts_receivable
| Value | {"amount": 22445000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2018-03-31) |
| Status | current |
| Entity | ACADIA PHARMACEUTICALS INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:37:10.561182+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/97aeefb7-a8da-46d8-925b-266ed587bb3c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-18-010844 · Open the official SEC filing →Retrieved: 2026-08-19T10:37:10.561182+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001070494/accounts-receivable/2018-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/97aeefb7-a8da-46d8-925b-266ed587bb3c
History
- no predecessors — first report